Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing

Abstract

Triple-negative breast cancers (TNBCs) are a heterogeneous set of tumors defined by an absence of actionable therapeutic targets (ER−,PR−,HER2−). Microdissected normal ductal epithelium from healthy volunteers represents a novel comparator to reveal insights into TNBC heterogeneity and to inform drug development. Using RNA-sequencing data from our institution and The Cancer Genome Atlas (TCGA) we compared the transcriptomes of 94 TNBCs, 20 microdissected normal breast tissues from healthy volunteers from the Susan G. Komen for the Cure Tissue Bank, and 10 histologically normal tissues adjacent to tumor. Pathway analysis comparing TNBCs to optimized normal controls of microdissected normal epithelium versus classic controls composed of adjacent normal tissue revealed distinct molecular signatures. Differential gene expression of TNBC compared with normal comparators demonstrated important findings for TNBC-specific clinical trials testing targeted agents; lack of over-expression for negative studies and over-expression in studies with drug activity. Next, by comparing each individual TNBC to the set of microdissected normals, we demonstrate that TNBC heterogeneity is attributable to transcriptional chaos, is associated with non-silent DNA mutational load, and explains transcriptional heterogeneity in addition to known molecular subtypes. Finally, chaos analysis identified 146 core genes dysregulated in >90% of TNBCs revealing an over-expressed central network. In conclusion, Use of microdissected normal ductal epithelium from healthy volunteers enables an optimized approach for studying TNBC and uncovers biological heterogeneity mediated by transcriptional chaos.

Causal network analysis of head and neck keloid tissue identifies potential master regulators

“…The hierarchical network master regulators, tributyrin and pyroxamide (activated drugs) and PENK and PRKG2 (inactivated molecules), are discussed based on three hypotheses. Application of an inhibitory chemical or drug in a causal network experiment results in the opposite expression effect as seen in the literature …”

Genetic Ancestry–dependent Differences in Breast Cancer–induced Field Defects in the Tumor-adjacent Normal Breast

“…This limitation was highlighted in another study, which compared TCGA "normal" breast transcriptome with the transcriptome of epithelial cells from the breast of healthy women. Significant differences were noted between these 2 sources of normal tissues (5). Reduction mammoplasty samples are also histologically abnormal compared with breast tissues from healthy women (6).…”

Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer

“…18 When considering a false discovery rate (FDR) < 0.05 with a fold change more than ± 2, we identified 3,197 differentially expressed genes in TNBCs vs. microdissected normal breast tissue (Supplementary Table 1). To perform drug development studies, we employed network and pathway analysis to identify key targetable pathways using these differentially expressed genes.…”